Literature DB >> 27319338

Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance.

Shelley R Starck1,2, Nilabh Shastri1.   

Abstract

Effective immune surveillance by CD8(+) cytotoxic T cells of intracellular microbes and cancer depends on the antigen presentation pathway. This pathway produces an optimal peptide repertoire for presentation by major histocompatibility (MHC) class I molecules (pMHCs I) on the cell surface. We have known for years that the pMHC I repertoire is a reflection of the intracellular protein pool. However, many studies have revealed that pMHCs I present peptides not only from precursors encoded in open-reading frames of mRNA transcripts but also cryptic peptides encoded in apparently 'untranslated' regions. These sources vastly increase the availability of peptides for presentation and immune evasion. Here, we review studies on the composition of the cryptic pMHC I repertoire, the immunological significance of these pMHC I, and the novel translational mechanisms that generate cryptic peptides from unusual sources.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  antigen presentation; antigen processing; cytotoxic T cells; major histocompatibility complex; protein synthesis

Mesh:

Substances:

Year:  2016        PMID: 27319338      PMCID: PMC4916849          DOI: 10.1111/imr.12434

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  80 in total

Review 1.  Translational control in stress and apoptosis.

Authors:  Martin Holcik; Nahum Sonenberg
Journal:  Nat Rev Mol Cell Biol       Date:  2005-04       Impact factor: 94.444

Review 2.  Alternative translational products and cryptic T cell epitopes: expecting the unexpected.

Authors:  On Ho; William R Green
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

Review 3.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?

Authors:  J W Yewdell; L C Antón; J R Bennink
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

4.  Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

Authors:  J Levitskaya; A Sharipo; A Leonchiks; A Ciechanover; M G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.

Authors:  Scott S Tykodi; Nobuharu Fujii; Nathalie Vigneron; Sharon M Lu; Jeffrey K Mito; Maureen X Miranda; Jeffrey Chou; Lilien N Voong; John A Thompson; Brenda M Sandmaier; Peter Cresswell; Benoît Van den Eynde; Stanley R Riddell; Edus H Warren
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

6.  Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex.

Authors:  A Kelly; S H Powis; L A Kerr; I Mockridge; T Elliott; J Bastin; B Uchanska-Ziegler; A Ziegler; J Trowsdale; A Townsend
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

7.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.

Authors:  Hyun Jin Kwun; Suzane Ramos da Silva; Ishita M Shah; Neil Blake; Patrick S Moore; Yuan Chang
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

8.  Cryptic MHC class I-binding peptides are revealed by aminoglycoside-induced stop codon read-through into the 3' UTR.

Authors:  Elliot Goodenough; Tara M Robinson; Matthew B Zook; Kevin M Flanigan; John F Atkins; Michael T Howard; Laurence C Eisenlohr
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

9.  Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling.

Authors:  Nicholas T Ingolia; Sina Ghaemmaghami; John R S Newman; Jonathan S Weissman
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

10.  A distinct translation initiation mechanism generates cryptic peptides for immune surveillance.

Authors:  Shelley R Starck; Yongkai Ow; Vivian Jiang; Maria Tokuyama; Mark Rivera; Xin Qi; Richard W Roberts; Nilabh Shastri
Journal:  PLoS One       Date:  2008-10-21       Impact factor: 3.240

View more
  23 in total

1.  Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance.

Authors:  Jiajie Wei; Rigel J Kishton; Matthew Angel; Crystal S Conn; Nicole Dalla-Venezia; Virginie Marcel; Anne Vincent; Frédéric Catez; Sabrina Ferré; Lilia Ayadi; Virginie Marchand; Devin Dersh; James S Gibbs; Ivaylo P Ivanov; Nathan Fridlyand; Yohann Couté; Jean-Jacques Diaz; Shu-Bing Qian; Louis M Staudt; Nicholas P Restifo; Jonathan W Yewdell
Journal:  Mol Cell       Date:  2019-01-31       Impact factor: 17.970

2.  Alternative Start Sites Downstream of Non-Sense Mutations Drive Antigen Presentation and Tolerance Induction to C-Terminal Epitopes.

Authors:  Scott N Ashley; Suryanarayan Somanathan; Christian Hinderer; Maxwell Arias; Deirdre McMenamin; Christine Draper; James M Wilson
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

3.  A close-up view of codon selection in eukaryotic initiation.

Authors:  Christoffer Lind; Mauricio Esguerra; Johan Åqvist
Journal:  RNA Biol       Date:  2017-03-24       Impact factor: 4.652

4.  Anti-tumour immunity induces aberrant peptide presentation in melanoma.

Authors:  Osnat Bartok; Abhijeet Pataskar; Remco Nagel; Maarja Laos; Eden Goldfarb; Deborah Hayoun; Ronen Levy; Pierre-Rene Körner; Inger Z M Kreuger; Julien Champagne; Esther A Zaal; Onno B Bleijerveld; Xinyao Huang; Juliana Kenski; Jennifer Wargo; Alexander Brandis; Yishai Levin; Orel Mizrahi; Michal Alon; Sacha Lebon; Weiwen Yang; Morten M Nielsen; Noam Stern-Ginossar; Maarten Altelaar; Celia R Berkers; Tamar Geiger; Daniel S Peeper; Johanna Olweus; Yardena Samuels; Reuven Agami
Journal:  Nature       Date:  2020-12-16       Impact factor: 49.962

5.  Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors.

Authors:  Assaf Kacen; Aaron Javitt; Matthias P Kramer; David Morgenstern; Tomer Tsaban; Merav D Shmueli; Guo Ci Teo; Felipe da Veiga Leprevost; Eilon Barnea; Fengchao Yu; Arie Admon; Lea Eisenbach; Yardena Samuels; Ora Schueler-Furman; Yishai Levin; Alexey I Nesvizhskii; Yifat Merbl
Journal:  Nat Biotechnol       Date:  2022-10-06       Impact factor: 68.164

Review 6.  The plasticity of mRNA translation during cancer progression and therapy resistance.

Authors:  Lucilla Fabbri; Alina Chakraborty; Caroline Robert; Stéphan Vagner
Journal:  Nat Rev Cancer       Date:  2021-08-02       Impact factor: 60.716

7.  Influenza A Virus Negative Strand RNA Is Translated for CD8+ T Cell Immunosurveillance.

Authors:  Heather D Hickman; Jacqueline W Mays; James Gibbs; Ivan Kosik; Javier G Magadán; Kazuyo Takeda; Suman Das; Glennys V Reynoso; Barbara F Ngudiankama; JiaJie Wei; John P Shannon; Daniel McManus; Jonathan W Yewdell
Journal:  J Immunol       Date:  2018-07-16       Impact factor: 5.422

Review 8.  From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.

Authors:  John F Atkins; Kate M O'Connor; Pramod R Bhatt; Gary Loughran
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.048

9.  Most non-canonical proteins uniquely populate the proteome or immunopeptidome.

Authors:  Maria Virginia Ruiz Cuevas; Marie-Pierre Hardy; Jaroslav Hollý; Éric Bonneil; Chantal Durette; Mathieu Courcelles; Joël Lanoix; Caroline Côté; Louis M Staudt; Sébastien Lemieux; Pierre Thibault; Claude Perreault; Jonathan W Yewdell
Journal:  Cell Rep       Date:  2021-03-09       Impact factor: 9.423

10.  Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Authors:  Shira Weingarten-Gabbay; Susan Klaeger; Siranush Sarkizova; Leah R Pearlman; Da-Yuan Chen; Kathleen M E Gallagher; Matthew R Bauer; Hannah B Taylor; W Augustine Dunn; Christina Tarr; John Sidney; Suzanna Rachimi; Hasahn L Conway; Katelin Katsis; Yuntong Wang; Del Leistritz-Edwards; Melissa R Durkin; Christopher H Tomkins-Tinch; Yaara Finkel; Aharon Nachshon; Matteo Gentili; Keith D Rivera; Isabel P Carulli; Vipheaviny A Chea; Abishek Chandrashekar; Cansu Cimen Bozkus; Mary Carrington; Nina Bhardwaj; Dan H Barouch; Alessandro Sette; Marcela V Maus; Charles M Rice; Karl R Clauser; Derin B Keskin; Daniel C Pregibon; Nir Hacohen; Steven A Carr; Jennifer G Abelin; Mohsan Saeed; Pardis C Sabeti
Journal:  Cell       Date:  2021-06-03       Impact factor: 66.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.